Clinical Trial

Oxygen Extraction-guided Transfusion

Study acronym: OXYTRIP
Recruiting
View on ClinicalTrials.gov →
Summary
In critically ill patients, optimized strategies for red blood cells transfusion (RBCT) are still controversial. Most recent guidelines suggest that clinical practice in ICU setting should follow a restrictive approach to RBCT (i.e., hemoglonim level \< 7.0 g/dL).In our previous study, oxygen extraction ratio (O2ER) has shown good performance as a marker to identify the correct timing for RBCT, potentially affecting 90-day mortality in non-bleeding, critically ill patients \[11\]. Moreover, our data suggested that an individualized strategy for RBCT may reduce the incidence of acute kidney injury (AKI), which is possibly related to a better delivery of oxygen and organ perfusion.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-11-01 -> 2026-12-01 2026-08-01
minor Completion pushed: 2027-01-01 -> 2027-03-01 2026-08-01
Trial Details
NCT Number NCT06102590
Lead Sponsor Università degli Studi di Ferrara
Conditions Blood Transfusion
Enrollment 324 participants
Start Date 2023-11-04
Primary Completion 2026-12-01 (estimated)
Study Completion 2027-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-31